JP2003510257A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003510257A5 JP2003510257A5 JP2001525222A JP2001525222A JP2003510257A5 JP 2003510257 A5 JP2003510257 A5 JP 2003510257A5 JP 2001525222 A JP2001525222 A JP 2001525222A JP 2001525222 A JP2001525222 A JP 2001525222A JP 2003510257 A5 JP2003510257 A5 JP 2003510257A5
- Authority
- JP
- Japan
- Prior art keywords
- cys
- lys
- asn
- arg
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15513599P | 1999-09-22 | 1999-09-22 | |
| US60/155,135 | 1999-09-22 | ||
| US21943800P | 2000-07-20 | 2000-07-20 | |
| US60/219,438 | 2000-07-20 | ||
| PCT/US2000/025827 WO2001021648A1 (en) | 1999-09-22 | 2000-09-21 | Uses of kappa-conotoxin pviia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003510257A JP2003510257A (ja) | 2003-03-18 |
| JP2003510257A5 true JP2003510257A5 (enExample) | 2007-11-01 |
Family
ID=26852034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001525222A Pending JP2003510257A (ja) | 1999-09-22 | 2000-09-21 | カッパ−コノトキシンｐｖｉｉａの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20040092447A1 (enExample) |
| EP (1) | EP1218407A4 (enExample) |
| JP (1) | JP2003510257A (enExample) |
| AU (1) | AU778182B2 (enExample) |
| CA (1) | CA2385047A1 (enExample) |
| WO (1) | WO2001021648A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003533178A (ja) | 1999-12-30 | 2003-11-11 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション | Ｏ−スーパーファミリー・コノトキシンペプチド |
| AUPR506601A0 (en) * | 2001-05-17 | 2001-06-07 | Australian National University, The | Method of modulating the activity of calcium channels in cardiac cells and reagents therefor |
| US20030224343A1 (en) * | 2002-01-29 | 2003-12-04 | University Of Utah Research Foundation | Kappa-PVIIA-related conotoxins as organ protectants |
| US20040229780A1 (en) * | 2002-09-20 | 2004-11-18 | Olivera Baldomero M. | KappaM-conopeptides as organ protectants |
| US20060178303A1 (en) * | 2004-09-09 | 2006-08-10 | University Of Utah Research Foundation | Potassium channel blockers |
| US10531655B2 (en) | 2011-12-02 | 2020-01-14 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| CN107074909B (zh) * | 2014-09-30 | 2020-11-27 | 深圳华大基因科技有限公司 | 芋螺毒素多肽κ-CPTx-btl01、其制备方法及应用 |
| EP3202782B1 (en) * | 2014-09-30 | 2019-10-16 | BGI Shenzhen Co., Limited | Conotoxin polypeptide kappa-cptx-bt103, and method for preparation thereof and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672682A (en) * | 1996-03-18 | 1997-09-30 | University Of Utah Research Foundation | Conotoxin peptide PVIIA |
| US6333337B1 (en) * | 1998-01-27 | 2001-12-25 | Icagen, Inc. | Potassium channel inhibitors |
-
2000
- 2000-09-21 CA CA002385047A patent/CA2385047A1/en not_active Abandoned
- 2000-09-21 WO PCT/US2000/025827 patent/WO2001021648A1/en not_active Ceased
- 2000-09-21 JP JP2001525222A patent/JP2003510257A/ja active Pending
- 2000-09-21 AU AU75968/00A patent/AU778182B2/en not_active Ceased
- 2000-09-21 EP EP00965219A patent/EP1218407A4/en not_active Withdrawn
-
2003
- 2003-07-28 US US10/627,685 patent/US20040092447A1/en not_active Abandoned
-
2005
- 2005-10-27 US US11/259,039 patent/US20060040312A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5446130A (en) | Parathyroid hormone antagonists | |
| US5726156A (en) | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels | |
| DK2473518T3 (en) | Stabilized melanocortin ligands | |
| US5786332A (en) | Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels | |
| JPS62500871A (ja) | 薬理活性を有するジペプチド化合物及びそれを含む組成物 | |
| CA2596597A1 (en) | Method for stimulation collagen synthesis and/or kgf expression | |
| WO1994007815A2 (en) | Small peptide anaphylatoxin receptor ligands | |
| AU599177B2 (en) | 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use | |
| WO2002020561A1 (en) | Novel polypeptides and anti-hiv drugs containing the same | |
| US5387671A (en) | Hexa- and heptapeptide anaphylatoxin-receptor ligands | |
| EP1485345B1 (de) | Hemmstoffe der urokinase, ihre herstellung und verwendung | |
| US6057295A (en) | Oligopeptides derived from C-reactive protein fragments | |
| JP2003528814A5 (enExample) | ||
| AU2018293467B2 (en) | Pro-drug peptide with improved pharmaceutical properties | |
| JP2003501109A5 (enExample) | ||
| WO2011060018A2 (en) | Compositions and methods for using peptides, modified peptides, peptidomimetics and fibrin derivatives | |
| JP5689892B2 (ja) | ２−アミノ−３−メチル−ヘキサ−５エン酸、及びバシトラシン等のペプチドの生成におけるその使用方法 | |
| CA2719940A1 (en) | Methods for treating acute myocardial infarction | |
| Birr et al. | The hexa-and pentapeptide extension of proalbumin I. Chemical synthesis of serum albumin propeptides | |
| JP2007161696A (ja) | 新規なヘプタペプチド及びプロリルエンドペプチダーゼ阻害剤 | |
| AU633128B2 (en) | Anticoagulant peptides | |
| JPH08225457A (ja) | 癌転移抑制用組成物 | |
| JPH07233084A (ja) | 化学療法剤効果増強剤 | |
| JPH04321699A (ja) | 新規な利尿ペプチド | |
| KR20130032787A (ko) | 심혈관 질환 예방 및 치료용 펩타이드 및 이의 용도 |